V. K. Gupta, “Bimatoprost Ophthalmic Solution (BOS) 0.3 mg w/v for 1 Open Trial of Long-term Preventive Therapy of Migraine in 3 patients with Pathophysiologic Shift from Brain to Eye”, J Neurosci Neurol Disord, vol. 7, no. 2, pp. 134–154, Nov. 2023.